Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3411687rdf:typepubmed:Citationlld:pubmed
pubmed-article:3411687lifeskim:mentionsumls-concept:C1533685lld:lifeskim
pubmed-article:3411687lifeskim:mentionsumls-concept:C0597639lld:lifeskim
pubmed-article:3411687lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:3411687lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:3411687lifeskim:mentionsumls-concept:C0149751lld:lifeskim
pubmed-article:3411687pubmed:issue3lld:pubmed
pubmed-article:3411687pubmed:dateCreated1988-9-28lld:pubmed
pubmed-article:3411687pubmed:abstractTextFibrotic penile lesions developed in 4 patients who had undergone intracorporeal injection of vasoactive agents. These lesions persisted for at least 3 months, and in some instances they caused pain and curvature of the penis during erection.lld:pubmed
pubmed-article:3411687pubmed:languageenglld:pubmed
pubmed-article:3411687pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3411687pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3411687pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3411687pubmed:statusMEDLINElld:pubmed
pubmed-article:3411687pubmed:monthSeplld:pubmed
pubmed-article:3411687pubmed:issn0022-5347lld:pubmed
pubmed-article:3411687pubmed:authorpubmed-author:CarltonC...lld:pubmed
pubmed-article:3411687pubmed:authorpubmed-author:CorriereJ...lld:pubmed
pubmed-article:3411687pubmed:authorpubmed-author:BensonG SGSlld:pubmed
pubmed-article:3411687pubmed:authorpubmed-author:FishmanI JIJlld:pubmed
pubmed-article:3411687pubmed:issnTypePrintlld:pubmed
pubmed-article:3411687pubmed:volume140lld:pubmed
pubmed-article:3411687pubmed:ownerNLMlld:pubmed
pubmed-article:3411687pubmed:authorsCompleteYlld:pubmed
pubmed-article:3411687pubmed:pagination615-7lld:pubmed
pubmed-article:3411687pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:meshHeadingpubmed-meshheading:3411687-...lld:pubmed
pubmed-article:3411687pubmed:year1988lld:pubmed
pubmed-article:3411687pubmed:articleTitleDevelopment of fibrotic penile lesions secondary to the intracorporeal injection of vasoactive agents.lld:pubmed
pubmed-article:3411687pubmed:affiliationDepartment of Surgery, University of Texas Medical School, Houston 77030.lld:pubmed
pubmed-article:3411687pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3411687pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3411687lld:pubmed